A biochemical analysis linking APOBEC3A to disparate HIV-1 restriction and skin cancer

Journal of Biological Chemistry

Volumn 288, Issue 41, 2013, Pages 29294-29304

  Pham, Phuong ^a   Landolph, Alice ^a   Mendez, Carlos ^a   Li, Nancy ^a   Goodman, Myron F ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL ANALYSIS; BIOCHEMICAL DATA; BIOLOGICAL PROCESS; DEOXYCYTIDINE DEAMINASE; MEMBRANE COMPARTMENT; MOLECULAR BASIS; OPTIMAL ACTIVITY; SPECIFIC ACTIVITY;

AMINES; DIMERS; DISEASES; TRANSCRIPTION;

DERMATOLOGY;

APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3A; DEOXYCYTIDINE PHOSPHATE DEAMINASE; DIMER; GENOMIC DNA; UNCLASSIFIED DRUG;

ACIDITY; ANIMAL CELL; ARTICLE; AUTOPHAGOSOME; BONE MARROW CELL; CARCINOGENESIS; CATALYSIS; CELL NUCLEUS; CELL PH; CHEMICAL ANALYSIS; CONTROLLED STUDY; DEAMINATION; DISEASE ASSOCIATION; ENZYME ACTIVITY; ENZYME REGULATION; ENZYME SPECIFICITY; ENZYME STRUCTURE; GENE MUTATION; GENE REPLICATION; GENE TARGETING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; INSECT CELL; KERATINOCYTE; MEMBRANE STRUCTURE; MOLECULAR MECHANICS; MUTAGENESIS; NONHUMAN; PRECANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SKIN CANCER; SKIN DEFECT; TRANSCRIPTION INITIATION; ULTRAVIOLET RADIATION; VIRUS INACTIVATION; VIRUS ISOLATION; VIRUS MUTATION;

APOBEC; DEOXYCYTIDINE DEAMINASE; DNA DAMAGE; HIV-1; MUTAGENESIS; MYELOID CELL; NUCLEIC ACID ENZYMOLOGY; SKIN CANCER;

AMINO ACID SEQUENCE; ANIMALS; ANISOTROPY; BASE SEQUENCE; CYTIDINE DEAMINASE; DNA, SINGLE-STRANDED; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FLUOROMETRY; HIV-1; HUMANS; HYDROGEN-ION CONCENTRATION; KERATINOCYTES; MACROPHAGES; MUTATION; NUCLEOTIDE MOTIFS; PROTEIN BINDING; PROTEINS; SF9 CELLS; SKIN NEOPLASMS; SUBSTRATE SPECIFICITY; UP-REGULATION;

EID: 84885641866     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.504175     Document Type: Article

References (62)

1. Jaszczur, M., Bertram, J. G., Pham, P., Scharff, M. D., and Goodman, M. F. (2013) AID and Apobec3G haphazard deamination and mutational diversity. Cell. Mol. Life Sci. 70, 3089-3108
2. Chiu, Y. L., and Greene, W. C. (2008) The APOBEC3 cytidine deaminases. An innate defensive network opposing exogenous retroviruses and endogenous retroelements. Annu. Rev. Immunol. 26, 317-353
3. Di Noia, J. M., and Neuberger, M. S. (2007) Molecular mechanisms of antibody somatic hypermutation. Annu. Rev. Biochem. 76, 1-22
4. Peled, J. U., Kuang, F. L., Iglesias-Ussel, M. D., Roa, S., Kalis, S. L., Goodman, M. F., and Scharff, M. D. (2008) The biochemistry of somatic hypermutation. Annu. Rev. Immunol. 26, 481-511
5. Mangeat, B., Turelli, P., Caron, G., Friedli, M., Perrin, L., and Trono, D. (2003) Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts. Nature 424, 99-103
6. Zhang, H., Yang, B., Pomerantz, R. J., Zhang, C., Arunachalam, S. C., and Gao, L. (2003) The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA. Nature 424, 94-98
7. Lecossier, D., Bouchonnet, F., Clavel, F., and Hance, A. J. (2003) Hypermutation of HIV-1 DNA in the absence of the Vif protein. Science 300, 1112
8. Peng, G., Greenwell-Wild, T., Nares, S., Jin, W., Lei, K. J., Rangel, Z. G., Munson, P. J., and Wahl, S. M. (2007) Myeloid differentiation and susceptibility to HIV-1 are linked to APOBEC3 expression. Blood 110, 393-400
9. Berger, G., Durand, S., Fargier, G., Nguyen, X. N., Cordeil, S., Bouaziz, S., Muriaux, D., Darlix, J. L., and Cimarelli, A. (2011) APOBEC3A is a specific inhibitor of the early phases of HIV-1 infection in myeloid cells. PLoS Pathog. 7, e1002221
10. Koning, F. A., Goujon, C., Bauby, H., and Malim, M. H. (2011) Target cell-mediated editing of HIV-1 cDNA by APOBEC3 proteins in human macrophages. J. Virol. 85, 13448-13452
11. Goujon, C., and Malim, M. H. (2010) Characterization of the alpha interferon- induced postentry block to HIV-1 infection in primary human macrophages and T cells. J. Virol. 84, 9254-9266
12. Cheney, K. M., and McKnight, Á. (2010) Interferon-alpha mediates restriction of human immunodeficiency virus type-1 replication in primary human macrophages at an early stage of replication. PLoS One 5, e13521
13. Chen, H., Lilley, C. E., Yu, Q., Lee, D. V., Chou, J., Narvaiza, I., Landau, N. R., and Weitzman, M. D. (2006) APOBEC3A is a potent inhibitor of adeno-associated virus and retrotransposons. Curr. Biol. 16, 480-485
14. Koning, F. A., Newman, E. N., Kim, E. Y., Kunstman, K. J., Wolinsky, S. M., and Malim, M. H. (2009) Defining APOBEC3 expression patterns in human tissues and hematopoietic cell subsets. J. Virol. 83, 9474-9485
15. Thielen, B. K., McNevin, J. P., McElrath, M. J., Hunt, B. V., Klein, K. C., and Lingappa, J. R. (2010) Innate immune signaling induces high levels of TC-specific deaminase activity in primary monocyte-derived cells through expression of APOBEC3A isoforms. J. Biol. Chem. 285, 27753-27766
16. Refsland, E. W., Stenglein, M. D., Shindo, K., Albin, J. S., Brown, W. L., and Harris, R. S. (2010) Quantitative profiling of the full APOBEC3 mRNA repertoire in lymphocytes and tissues. Implications for HIV-1 restriction. Nucleic Acids Res. 38, 4274-4284
17. Aynaud, M. M., Suspène, R., Vidalain, P. O., Mussil, B., Guétard, D., Tangy, F., Wain-Hobson, S., and Vartanian, J. P. (2012) Human Tribbles 3 protects nuclear DNA from cytidine deamination by APOBEC3A. J. Biol. Chem. 287, 39182-39192
18. Land, A. M., Law, E. K., Carpenter, M. A., Lackey, L., Brown, W. L., and Harris, R. S. (2013) Endogenous APOBEC3A DNA cytosine deaminase is cytoplasmic and nongenotoxic. J. Biol. Chem. 288, 17253-17260
19. Lackey, L., Law, E. K., Brown, W. L., and Harris, R. S. (2013) Subcellular localization of the APOBEC3 proteins during mitosis and implications for genomic DNA deamination. Cell Cycle 12, 762-772
20. Suspène, R., Aynaud, M. M., Guétard, D., Henry, M., Eckhoff, G., Marchio, A., Pineau, P., Dejean, A., Vartanian, J. P., and Wain-Hobson, S. (2011) Somatic hypermutation of human mitochondrial and nuclear DNA by APOBEC3 cytidine deaminases, a pathway for DNA catabolism. Proc. Natl. Acad. Sci. U.S.A. 108, 4858-4863
21. Vartanian, J. P., Guétard, D., Henry, M., and Wain-Hobson, S. (2008) Evidence for editing of human papillomavirus DNA by APOBEC3 in benign and precancerous lesions. Science 320, 230-233
22. Narvaiza, I., Linfesty, D. C., Greener, B. N., Hakata, Y., Pintel, D. J., Logue, E., Landau, N. R., and Weitzman, M. D. (2009) Deaminase-independent inhibition of parvoviruses by the APOBEC3A cytidine deaminase. PLoS Pathog. 5, e1000439
23. Wiegand, H. L., and Cullen, B. R. (2007) Inhibition of alpharetrovirus replication by a range of human APOBEC3 proteins. J. Virol. 81, 13694-13699
24. Ooms, M., Krikoni, A., Kress, A. K., Simon, V., and Münk, C. (2012) APOBEC3A, APOBEC3B, and APOBEC3H haplotype 2 restrict human T-lymphotropic virus type 1. J. Virol. 86, 6097-6108
25. Stenglein, M. D., Burns, M. B., Li, M., Lengyel, J., and Harris, R. S. (2010) APOBEC3 proteins mediate the clearance of foreign DNA from human cells. Nat. Struct. Mol. Biol. 17, 222-229
26. Bogerd, H. P., Wiegand, H. L., Hulme, A. E., Garcia-Perez, J. L., O'Shea, K. S., Moran, J. V., and Cullen, B. R. (2006) Cellular inhibitors of long interspersed element 1 and Alu retrotransposition. Proc. Natl. Acad. Sci. U.S.A. 103, 8780-8785
27. Kinomoto, M., Kanno, T., Shimura, M., Ishizaka, Y., Kojima, A., Kurata, T., Sata, T., and Tokunaga, K. (2007) All APOBEC3 family proteins differentially inhibit LINE-1 retrotransposition. Nucleic Acids Res. 35, 2955-2964
28. Bulliard, Y., Narvaiza, I., Bertero, A., Peddi, S., Röhrig, U. F., Ortiz, M., Zoete, V., Castro-Díaz, N., Turelli, P., Telenti, A., Michielin, O., Weitzman, M. D., and Trono, D. (2011) Structure-function analyses point to a polynucleotide-accommodating groove essential for APOBEC3A restriction activities. J. Virol. 85, 1765-1776
29. Landry, S., Narvaiza, I., Linfesty, D. C., and Weitzman, M. D. (2011) APOBEC3A can activate the DNA damage response and cause cell-cycle arrest. EMBO Rep. 12, 444-450
30. Burns, M. B., Lackey, L., Carpenter, M. A., Rathore, A., Land, A. M., Leonard, B., Refsland, E. W., Kotandeniya, D., Tretyakova, N., Nikas, J. B., Yee, D., Temiz, N. A., Donohue, D. E., McDougle, R. M., Brown, W. L., Law, E. K., and Harris, R. S. (2013) APOBEC3B is an enzymatic source of mutation in breast cancer. Nature 494, 366-370
31. Taylor, B. J., Nik-Zainal, S., Wu, Y. L., Stebbings, L. A., Raine, K., Campbell, P. J., Rada, C., Stratton, M. R., and Neuberger, M. S. (2013) DNA deaminases induce break-associated mutation showers with implication of APOBEC3B and 3A in breast cancer kataegis. Elife 2, e00534
32. Klein, I. A., Resch, W., Jankovic, M., Oliveira, T., Yamane, A., Nakahashi, H., Di Virgilio, M., Bothmer, A., Nussenzweig, A., Robbiani, D. F., Casellas, R., and Nussenzweig, M. C. (2011) Translocation-capture sequencing reveals the extent and nature of chromosomal rearrangements in B lymphocytes. Cell 147, 95-106
33. Jiang, Y., Soong, T. D., Wang, L., Melnick, A. M., and Elemento, O. (2012) Genome-wide detection of genes targeted by non-Ig somatic hypermutation in lymphoma. PLoS One 7, e40332
34. Madsen, P., Anant, S., Rasmussen, H. H., Gromov, P., Vorum, H., Dumanski, J. P., Tommerup, N., Collins, J. E., Wright, C. L., Dunham, I., MacGinnitie, A. J., Davidson, N. O., and Celis, J. E. (1999) Psoriasis upregulated phorbolin-1 shares structural but not functional similarity to the mRNA-editing protein apobec-1. J. Invest. Dermatol. 113, 162-169
35. Trivedi, N. R., Gilliland, K. L., Zhao, W., Liu, W., and Thiboutot, D. M. (2006) Gene array expression profiling in acne lesions reveals marked upregulation of genes involved in inflammation and matrix remodeling. J. Invest. Dermatol. 126, 1071-1079
36. Pham, P., Bransteitter, R., Petruska, J., and Goodman, M. F. (2003) Processive AID-catalysed cytosine deamination on single-stranded DNA simulates somatic hypermutation. Nature 424, 103-107
37. Mu, Y., Prochnow, C., Pham, P., Chen, X. S., and Goodman, M. F. (2012)A structural basis for the biochemical behavior of activation-induced deoxycytidine deaminase class-switch recombination-defective hyper-IgM-2 mutants. J. Biol. Chem. 287, 28007-28016
38. Pham, P., Calabrese, P., Park, S. J., and Goodman, M. F. (2011) Analysis of a single-stranded DNA-scanning process in which activation-induced deoxycytidine deaminase (AID) deaminates C to U haphazardly and inefficiently to ensure mutational diversity. J. Biol. Chem. 286, 24931-24942
39. Pham, P., Chelico, L., and Goodman, M. F. (2007) DNA deaminases AID and APOBEC3G act processively on single-stranded DNA.DNARepair 6, 689-692; author reply 693-694
40. Chelico, L., Pham, P., Calabrese, P., and Goodman, M. F. (2006) APOBEC3GDNAdeaminase acts processively 3'→5' on single-stranded DNA. Nat. Struct. Mol. Biol. 13, 392-399
41. Chelico, L., Sacho, E. J., Erie, D. A., and Goodman, M. F. (2008) A model for oligomeric regulation of APOBEC3G cytosine deaminase-dependent restriction of HIV. J. Biol. Chem. 283, 13780-13791
42. Love, R. P., Xu, H., and Chelico, L. (2012) Biochemical analysis of hypermutation by the deoxycytidine deaminase APOBEC3A. J. Biol. Chem. 287, 30812-30822
43. Carpenter, M. A., Li, M., Rathore, A., Lackey, L., Law, E. K., Land, A. M., Leonard, B., Shandilya, S. M., Bohn, M. F., Schiffer, C. A., Brown, W. L., and Harris, R. S. (2012) Methylcytosine and normal cytosine deamination by the foreign DNA restriction enzyme APOBEC3A. J. Biol. Chem. 287, 34801-34808
44. Byeon, I. J., Ahn, J., Mitra, M., Byeon, C. H., Hercík, K., Hritz, J., Charlton, L. M., Levin, J. G., and Gronenborn, A. M. (2013) NMR structure of human restriction factor APOBEC3A reveals substrate binding and enzyme specificity. Nat. Commun. 4, 1890
45. Giglia-Mari, G., and Sarasin, A. (2003) TP53 mutations in human skin cancers. Hum. Mutat. 21, 217-228
46. Skinner, A. M., and Turker, M. S. (2008) High frequency induction of CC to TT tandem mutations inDNArepair-proficient mammalian cells. Photochem. Photobiol. 84, 222-227
47. Seksek, O., and Bolard, J. (1996) Nuclear pH gradient in mammalian cells revealed by laser microspectrofluorimetry. J. Cell Sci. 109, 257-262
48. Demaurex, N. (2002) pH Homeostasis of cellular organelles. News Physiol. Sci. 17, 1-5
49. Kyei, G. B., Dinkins, C., Davis, A. S., Roberts, E., Singh, S. B., Dong, C., Wu, L., Kominami, E., Ueno, T., Yamamoto, A., Federico, M., Panganiban, A., Vergne, I., and Deretic, V. (2009) Autophagy pathway intersects with HIV-1 biosynthesis and regulates viral yields in macrophages. J. Cell Biol. 186, 255-268
50. Espert, L., Varbanov, M., Robert-Hebmann, V., Sagnier, S., Robbins, I., Sanchez, F., Lafont, V., and Biard-Piechaczyk, M. (2009) Differential role of autophagy in CD4 T cells and macrophages during X4 and R5 HIV-1 infection. PLoS One 4, e5787
51. Killian, M. S. (2012) Dual role of autophagy in HIV-1 replication and pathogenesis. AIDS Res. Ther. 9, 16
52. Bishop, K. N., Holmes, R. K., Sheehy, A. M., Davidson, N. O., Cho, S. J., and Malim, M. H. (2004) Cytidine deamination of retroviral DNA by diverse APOBEC proteins. Curr. Biol. 14, 1392-1396
53. Doehle, B. P., Schäfer, A., Wiegand, H. L., Bogerd, H. P., and Cullen, B. R. (2005) Differential sensitivity of murine leukemia virus to APOBEC3-mediated inhibition is governed by virion exclusion. J. Virol. 79, 8201-8207
54. Xie, Z., and Klionsky, D. J. (2007) Autophagosome formation. Core machinery and adaptations. Nat. Cell Biol. 9, 1102-1109
55. Lukacs, G. L., Rotstein, O. D., and Grinstein, S. (1990) Phagosomal acidification is mediated by a vacuolar-type H+-ATPase in murine macrophages. J. Biol. Chem. 265, 21099-21107
56. Zhou, D., and Spector, S. A. (2008) Human immunodeficiency virus type-1 infection inhibits autophagy. AIDS 22, 695-699
57. Harjes, S., Solomon, W. C., Li, M., Chen, K. M., Harjes, E., Harris, R. S., and Matsuo, H. (2013) Impact of H216 on the DNA binding and catalytic activities of the HIV restriction factor APOBEC3G. J. Virol. 87, 7008-7014
58. Nik-Zainal, S., Alexandrov, L. B., Wedge, D. C., Van Loo, P., Greenman, C. D., Raine, K., Jones, D., Hinton, J., Marshall, J., Stebbings, L. A., Menzies, A., Martin, S., Leung, K., Chen, L., Leroy, C., Ramakrishna, M., Rance, R., Lau, K. W., Mudie, L. J., Varela, I., McBride, D. J., Bignell, G. R., Cooke, S. L., Shlien, A., Gamble, J., Whitmore, I., Maddison, M., Tarpey, P. S., Davies, H. R., Papaemmanuil, E., Stephens, P. J., McLaren, S., Butler, A. P., Teague, J. W., Jönsson, G., Garber, J. E., Silver, D., Miron, P., Fatima, A., Boyault, S., Langerød, A., Tutt, A., Martens, J. W., Aparicio, S. A., Borg, Å., Salomon, A. V., Thomas, G., Børresen-Dale, A. L., Richardson, A. L., Neuberger, M. S., Futreal, P. A., Campbell, P. J., and Stratton, M. R. (2012) Mutational processes molding the genomes of 21 breast cancers. Cell 149, 979-993
59. Lada, A. G., Dhar, A., Boissy, R. J., Hirano, M., Rubel, A. A., Rogozin, I. B., and Pavlov, Y. I. (2012) AID/APOBEC cytosine deaminase induces genome- wide kataegis. Biol. Direct 7, 47; discussion 47
60. Roberts, S. A., Sterling, J., Thompson, C., Harris, S., Mav, D., Shah, R., Klimczak, L. J., Kryukov, G. V., Malc, E., Mieczkowski, P. A., Resnick, M. A., and Gordenin, D. A. (2012) Clustered mutations in yeast and in human cancers can arise from damaged long single-strand DNA regions. Mol. Cell 46, 424-435
61. Senavirathne, G., Jaszczur, M., Auerbach, P. A., Upton, T. G., Chelico, L., Goodman, M. F., and Rueda, D. (2012) Single-stranded DNA scanning and deamination by APOBEC3G cytidine deaminase at single molecule resolution. J. Biol. Chem. 287, 15826-15835
62. Peng, W., and Shaw, B. R. (1996) Accelerated deamination of cytosine residues in UV-induced cyclobutane pyrimidine dimers leads to CC3TT transitions. Biochemistry 35, 10172-10181